Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_assertion description "[These studies provide the first direct proof that bicistronic siRNA construct for uPAR and cathepsin B (pUC) reduces Y925-FAK activity and this inhibition is rescued by overexpression of both uPAR and cathepsin B which clearly demonstrates that pUC could thus be a potential therapeutic approach as an anti-angiogenic agent in meningioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_assertion evidence source_evidence_literature NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_assertion SIO_000772 21347260 NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_assertion wasDerivedFrom befree-20140225 NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_assertion wasGeneratedBy ECO_0000203 NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP178156.RAvimd00a6hVAlHyZFTZr6F4LXX7-bCXNqTJD40NH2_TE130_provenance.